Showing results (421-430 of 1,835) with videos related to
Sort By:
Pageof 184
Onkologie|June 23, 2012
Breast cancer in 65-year-old or older patients: clinicopathological characteristics and prognosisLei Yao, You-Xue Zhang, Li-Hong Wang, et al.Onkologie|April 1, 1985
[Immunohistochemical demonstration of tumor-associated antigens in urinary bladder carcinomas using mono- and polyclonal antisera]W Friedmann, J Steffens, H LobeckOnkologie|April 1, 1979
[Bone marrow transplantation in severe aplastic anemia and acute leukemia]B Speck, J Sartorius, P Cornu, et al.Onkologie|September 26, 2012
Chronic graft versus host disease but not the intensity of conditioning has impact on survival after allogeneic hematopoietic stem cell transplantation for advanced hematological diseasesInken Hilgendorf, Daniel Wolff, Axel Nogai, et al.Onkologie|September 26, 2012
Prognostic role of serum cytokines in patients with nasopharyngeal carcinomaKe Lu, Xinglai Feng, Qinghua Deng, et al.Onkologie|September 26, 2012
Combination of trastuzumab and triple FLOT chemotherapy (5-fluorouracil/leucovorin, oxaliplatin, and docetaxel) in patients with HER2-positive metastatic gastric cancer: report of 3 casesSalah-Eddin Al-Batran, Wael Hozaeel, Elke JägerOnkologie|September 26, 2012
Gefitinib-induced hepatotoxicity in patients treated for non-small cell lung cancerJing Chen, Runxia Gu, Qiong Wang, et al.Onkologie|November 14, 2012
The MDM2 309 T/G polymorphism is associated with head and neck cancer risk especially in nasopharyngeal cancer: a meta-analysisYaowei Zhang, Yang Bai, Yong Zhang, et al.Onkologie|November 14, 2012
RASSF1A and ERCC1 expression levels might be predictive of prognosis in advanced, recurrent, and metastatic squamous cell carcinoma of the head and neck treated with docetaxel and cisplatinYong Park, Dae S Kim, Kyong H Park, et al.Pageof 184